ImmuPharma plc (GB:IMM) has released an update.
ImmuPharma plc has reported a change in major shareholdings, with Lanstead Capital Investors LP’s stake adjusting to 12.99% of the voting rights as of May 1, 2024. This marks a decrease from their previous notification, which indicated a 15.89% holding in the company. The change in share distribution is a significant event for current and potential investors, signaling movements within the company’s ownership structure.
For further insights into GB:IMM stock, check out TipRanks’ Stock Analysis page.
